The NGen supercluster has awarded $27 million in funding for 12 advanced manufacturing projects that can supply critical health care products to combat COVID-19. The funding includes $5 million for Providence Therapeutics and partner Northern RNA to establish manufacturing capacity in Calgary for Providence’s made-in-Canada vaccine.
Person: Jayson Myers
Superclusters’ projects still on track despite COVID-19
A R$ webinar with the CEOs of Canada’s five innovation superclusters reported on the impact of COVID-19
Strong industry leadership minus government red tape key to superclusters success
Strong industry leadership without burdensome government bureaucracy will be key to Canada’s superclusters’ success, R$ conference hears.
Smaller companies to benefit from Advanced Manufacturing Supercluster
Small Canadian manufacturing companies and technology firms will reap big benefits from the new Advanced Manufacturing Supercluster, says the chief executive leading the initiative.
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...